Cohort News

B3 GEL™ SYSTEM SUPPORTING RESEARCH: What Happens When You “Overapply” Tendon Protection? Surgeons may question their application of tendon protection devices: ” ?” A cadaveric study, carried out in conjunction with researchers at the University of Virginia, has the answer.... Read More →

Swedish MedTech company Multi4 Medical, chaired by renowned investor Erik Selin, has received FDA clearance for its patended technology for automated cancer treatment. The decision means that Multi4 is now approved for commercial sale in the U.S., the world’s largest... Read More →

SAN DIEGO and CHICAGO, June 30, 2025 /PRNewswire/ — HealthpointCapital, the leading private equity firm focused exclusively on musculoskeletal healthcare, today announced the acquisition of a majority stake in ImmersiveTouch, Inc. (“ImmersiveTouch” or the “Company”). ImmersiveTouch‘s ImmersiveView™ platform is a... Read More →

Effective September 15, CPT 31242 is no longer considered experimental, clearing an important barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland, June 30, 2025 /PRNewswire/ — Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced that... Read More →

Innovative procedure aims to ease symptoms and reduce hospitalizations Newswise — MINNEAPOLIS, June 30, 2025 /PRNewswire/ — InterShunt Technologies, Inc., a medical device company focused on developing minimally invasive treatments for heart failure, has officially kicked off its latest clinical... Read More →

EINDHOVEN, The Netherlands – June 26, 2025 – STENTiT, a pioneering medical device company, developing a novel class of stents with regenera6ve proper6es, today announced the successful implanta6on of its Resorbable Fibrillated Scaffold (RFS). As part of the VITAL-IT 1... Read More →

Julien Payen, cofounder and CEO of Lattice Medical, describes the company’s 3D-printed, resorbable breast implant that uses a patient’s own fat to regenerate natural breast tissue after a mastectomy. Lattice Medical has created a 3D-printed, resorbable implant called MATTISSE, designed... Read More →

West Lafayette, Ind. (June 23, 2025) – Amplified Sciences announced today that it has secured an exclusive global license to a patent from the University of California, San Francisco (UCSF) that helps enable PanCystPro, the company’s first product offered as... Read More →

GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, today announced that it has entered into an agreement with Immuno Cure, a prominent developer of DNA vaccines. Under... Read More →